ADHD Update
ADHD: How Pharmacotherapy Lowers the Risk of Dying from Unnatural Causes
In a new study of patients with attention deficit hyperactivity disorder (ADHD), the use of ADHD medication was associated with a statistically significant lower risk of all-cause mortality and death due to unnatural causes, such as accidents and overdoses.
Could Fevers in Early Childhood Trigger ADHD?
According to new research from a large, observational, case-control study, seizures caused by a high fever may be associated with a diagnosis of attention deficit hyperactivity disorder (ADHD).
Kids and ADHD: A Racially Diverse Analysis of Treatment Compliance
A new study examined the types of pharmacological and nonpharmacological therapies adolescents—minorities, largely—are using to treat attention deficit hyperactivity disorder (ADHD), and how well they’re sticking to them. The results may surprise you.
Treating Pediatric ADHD and Bipolar Disorder: A Delicate Balance
Stimulant medications, often used to treat pediatric ADHD, may pose risks for children with comorbid bipolar disorder, possibly including an earlier onset of BPD symptoms.
Is ADHD Diagnosis in Adults Clinically Valid?
Does adult-onset ADHD have clinical features that are distinct from ADHD diagnosed during childhood?
Adult ADHD is Linked to an Increased Risk of Incident Dementia
Results from a national cohort study demonstrated the presence of adult ADHD was associated with a 2.77-fold increased risk of dementia. These findings suggest the importance of monitoring for ADHD in older age.
ADHD Boosts Concussion Risk in Student Athletes, But Stimulant Meds May Aid Recovery
Analysis of nearly 45,000 medical records for NCAA athletes and military cadets found that ADHD and psychostimulant use increased concussion rates by approximately 20%-50%--but the use of ADHD medication was associated with faster symptom resolution.
ADHD: Is Treatment Continuation a Big Issue?
Yes, according to recent findings. Many patients stop taking their meds for attention deficit hyperactivity disorder within the first year. Late adolescence and early adulthood are particularly vulnerable times for medication discontinuation, often despite persistent symptoms.